Session Details
[27-14-am]Science for Drug Formulation 4, Controlled release/Targeting
Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 14 (C507, Bldg. 2, Area 2 [5F])
Chair: Kazunori Iwanaga, Hisanao Kishimoto
[27-14-am01S]"Stabilization of pH-responsive self-destructive liposomes by Tween 60 and DHSM"
○Sae Akaki1, Yusuke Kono1, Hiroyasu Takemoto2, Makoto Oba2, Masaki Morishita1, Ken-ichi Ogawara1 (1. Kobe Pharm Univ., 2. Grad. Sch. Med. Sci., Kyoto Pref Univ. Med.)
[27-14-am02S]Development of formulations with enhanced tumor selectivity and retention for boron neutron capture therapy
○Shota Tanaka1, Konoka Baba2, Kodai Yamashita2, Aoi Fujimaki2, Nodoka Aoki2, Itsuki Fukuda1, Daiki Tokura1, Kakeru Konarita1, Kensuke Suzuki3, Minoru Suzuki4, Takashi Temma4,5, Takahiro Nomoto1,2 (1. Grad. Sch. Arts Sci., UTokyo, 2. Coll. Arts Sci., UTokyo, 3. Stella Pharma, 4. Inst. for Integr. Radiat. Nucl. Sci., Kyoto Univ., 5. Fac. Pharm., Osaka Med. Pharm. Univ.)
[27-14-am03S]Optimized loading of nucleic acids into hippocampal neuron-targeted extracellular vesicles and their gene silencing effects.
○Mana Yamada1, Hikari Ama2, Susumu Suwabe2, Mariko Takeda-Morishita1,2, Noriyasu Kamei 1,2 (1. Grad. Sch. Pharm. Sci., Kobe Gakuin Univ., 2. Fac. Pharm. Sci., Kobe Gakuin Univ.)
[27-14-am04S]Design and evaluation of seasonal influenza vaccine using needle-free intraepidermal administration device
○Masahiro Ogura1, Riru Onigahara1, Toru Taharabaru1, Taishi Higashi1,2, Shogo Misumi1,2, Naoki Kishimoto1,2, Hirotoshi Adachi3, Masahiko Kikuchi2,4, Keiichi Motoyama1,2 (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. VDRC, 3. PassPort Technologies, Inc, 4. UTOPIA)
[27-14-am05S]Generalizing the development of protein-encapsulated nanoparticles using functional lipids
○Tatyuya Kobayashi1, Hiroyuki Koide1, Midori Watanabe1, Kenji Yamashita1, Yoshitaka Hamashima1, Takehisa Dewa2, Asai Tomohiro1 (1. Grad. Sch. Pharm. Sci.,Univ.of Shizuoka, 2. Grad. Sch. Eng.,Univ.of Nagoya Institute of Technology)
[27-14-am06S]In vivo targeting of renal fibrotic tissue with an amine-terminated PEG-modified liposomes
○Yuka Kano1, Haruka Takata1,2, Hitoshi Matsumoto1, Ayano Aihara1, Shingo Kobayashi1,2, Hidenori Andou1,2, Tatsuhiro Ishida1,2 (1. Inst. of Biomed. Sci., Tokushima Univ., 2. Innovative Res. Ctr. for DDS, Inst. of Biomed. Sci., Tokushima Univ.)
[27-14-am07]Intracellular Localization Analysis of Nanoparticle Formulations by Cryo-Electron Microscopy
○Miya Urui1, Kenichi Yoshihara1, Ryosuke Yoshioka2, Shinichi Hata3, Nobutaka Numoto4, Pi-Cheng Tsai4, Yuya Tsurudome2, Kentaro Ushijima2, Jian-Ren Shen4, Michiko Horiguchi1 (1. Grad. Sch. Pharm. Sci. Okayama Univ., 2. Pharm. Sci. Sanyo-Onoda City Univ., 3. Eng. Sanyo-Onoda City Univ., 4. RIIS Okayama Univ.)
[27-14-am08]Effects of lipid composition on pulmonary pharmacokinetics/toxicity of inhaled dry powder formulations for nanoparticle self-assembly
○Tomoyuki Okuda1, Yudai Kajiyama1, Hirokazu Okamoto1 (1. Fac. Pharm., Meijo Univ.)
[27-14-am09]Retro-Inverso Bradykinin–Conjugated Polymers Enhance Tumor Accumulation of Nanomedicines
○Mamoru Haratake1, Anthony Assumang1, Hideaki Nakamura1, Masaya Morimitsu1 (1. Sojo University)
[27-14-am10S]Spleen immunization with cellular membrane protein-bearing PEGylated liposomes successfully induces production of anti-membrane protein antibodies
○Takanori Higashi1, Hidenori Ando1,2, Shunto Yamamoto1, Haruki Tanaka1, Haruka Takata1,2, Shingo Kobayashi1,2, Tatsuhiro Ishida1,2 (1. Inst. of Biomed. Sci., Tokushima Univ., 2. Innovative Res. Ctr. for DDS, Inst. of Biomed. Sci., Tokushima Univ.)
